EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Identifying Daytime Hypercapnia Using Transcutaneous Carbon Dioxide Monitoring in Patients With Amyotrophic Lateral Sclerosis

Alexander H Morrison, Jose Victor Jimenez iD, Jesse Y Hsu, Lauren Elman, Philip J Choi, Jason Ackrivo iD

Muscle & Nerve · 2025-04 · 71 (4) · 611-619

DOI: 10.1002/mus.28366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 12.02.2025. Verfasst von Alexander H Morrison und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Neuroscience Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, U…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Hypercapnia, Carbon Dioxide, Blood Gas Monitoring, Transcutaneous. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Respiratory failure from hypoventilation is the most common cause of death in amyotrophic lateral sclerosis (ALS). However, ALS care rarely assesses hypercapnia, a physiologic measure of hypoventilation. We investigated the prevalence and clinical significance of daytime hypercapnia measured by transcutaneous carbon dioxide (tcCO 2 ) monitoring in patients with ALS.

Methods

This retrospective study included patients seen at two ALS clinics in the United States between 2012 and 2024 who had tcCO 2 measured concurrently with pulmonary function tests (PFTs), which included forced vital capacity (FVC) and, at one site, maximum inspiratory pressure (MIP). We assessed the prevalence of hypercapnia (tcCO 2 > 45 mmHg), the sensitivity and specificity of patient symptoms and PFTs for hypercapnia, and the relationship between hypercapnia and survival.

Results

Daytime hypercapnia was present in 33/328 (10%) patients at baseline. Hypercapnia was associated with an increased rate of death (aHR 2.1, 95% CI 1.4–3.3). Orthopnea or dyspnea was 70% sensitive for hypercapnia (95% CI 51%–84%). Absolute value of MIP (|MIP|) < 60 cmH 2 O was 95% sensitive (95% CI 74%–100%) and 22% specific (95% CI 16%–30%), FVC < 50% predicted was 33% sensitive (95% CI 18%–52%) and 82% specific (95% CI 78%–87%), and FVC < 80% predicted was 85% sensitive (95% CI 68%–95%) and 31% specific (95% CI 26%–36%) for hypercapnia.

Discussion

TcCO 2 monitoring identified strengths and weaknesses of PFTs in identifying hypercapnia in ALS. We found high sensitivity of |MIP| < 60 cmH 2 O and FVC < 80% predicted and high specificity of FVC < 50% predicted. Prospective studies should investigate the optimal clinical role for tcCO 2 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisHypercapniaCarbon DioxideBlood Gas Monitoring, TranscutaneousHumansMaleFemaleMiddle AgedRetrospective StudiesAgedRespiratory Function TestsVital CapacityAdult

Stichwörter der Autor:innen

ALSdaytime hypercapniaforced vital capacitymaximum inspiratory pressuretranscutaneous CO2

Substanzen

Carbon Dioxide

Autor:innen und Institutionen

  • Department of Neurology, The Neuroscience Research Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Internal Medicine, Yale New Haven Hospital, New Haven, Connecticut, USA.
  • Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Pulmonary, and Critical Care and Sleep Medicine, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
  • Pulmonary, Allergy, and Critical Care Division, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Jose Victor Jimenez, Jason Ackrivo

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Morrison, A. H., Jimenez, J. V., Hsu, J. Y., Elman, L., Choi, P. J., & Ackrivo, J. (2025). Identifying Daytime Hypercapnia Using Transcutaneous Carbon Dioxide Monitoring in Patients With Amyotrophic Lateral Sclerosis. Muscle & Nerve, 71(4), 611-619. https://doi.org/10.1002/mus.28366

Vancouver

Morrison AH, Jimenez JV, Hsu JY, Elman L, Choi PJ, Ackrivo J. Identifying Daytime Hypercapnia Using Transcutaneous Carbon Dioxide Monitoring in Patients With Amyotrophic Lateral Sclerosis. Muscle & Nerve. 2025;71(4):611-619. doi:10.1002/mus.28366

BibTeX
@article{Morrison2025,
  author = {Morrison, Alexander H and Jimenez, Jose Victor and Hsu, Jesse Y and Elman, Lauren and Choi, Philip J and Ackrivo, Jason},
  title = {Identifying Daytime Hypercapnia Using Transcutaneous Carbon Dioxide Monitoring in Patients With Amyotrophic Lateral Sclerosis},
  journal = {Muscle & Nerve},
  year = {2025},
  volume = {71},
  number = {4},
  pages = {611--619},
  doi = {10.1002/mus.28366}
}
Kostenlos starten →